These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7568061)

  • 1. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.
    Broder CC; Berger EA
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):9004-8. PubMed ID: 7568061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
    Alkhatib G; Broder CC; Berger EA
    J Virol; 1996 Aug; 70(8):5487-94. PubMed ID: 8764060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
    Gu R; Westervelt P; Ratner L
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T-cell lines.
    Jolly PE
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1057-65. PubMed ID: 9449539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
    Lusso P; Cocchi F; Balotta C; Markham PD; Louie A; Farci P; Pal R; Gallo RC; Reitz MS
    J Virol; 1995 Jun; 69(6):3712-20. PubMed ID: 7745720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.
    Yen PJ; Herschhorn A; Haim H; Salas I; Gu C; Sodroski J; Gabuzda D
    J Virol; 2014 May; 88(9):5014-28. PubMed ID: 24554659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
    Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP
    J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases.
    Isaacs SN; Yi Y; Singh A; Collman RG
    J Virol Methods; 1999 Aug; 81(1-2):55-61. PubMed ID: 10488761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.
    King DF; Siddiqui AA; Buffa V; Fischetti L; Gao Y; Stieh D; McKay PF; Rogers P; Ochsenbauer C; Kappes JC; Arts EJ; Shattock RJ
    J Virol; 2013 Jan; 87(2):890-9. PubMed ID: 23135721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
    O'Connell O; Repik A; Reeves JD; Gonzalez-Perez MP; Quitadamo B; Anton ED; Duenas-Decamp M; Peters P; Lin R; Zolla-Pazner S; Corti D; Wallace A; Wang S; Kong XP; Lu S; Clapham PR
    J Virol; 2013 Jan; 87(1):187-98. PubMed ID: 23055568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dual recombinant vaccinia virus vectors to assay viral glycoprotein-mediated fusion with transfection-resistant primary cell targets.
    Yi Y; Singh A; Cutilli J; Collman RG
    Methods Mol Biol; 2004; 269():333-46. PubMed ID: 15114024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    Nussbaum O; Broder CC; Berger EA
    J Virol; 1994 Sep; 68(9):5411-22. PubMed ID: 8057423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
    Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism.
    Morikita T; Maeda Y; Fujii S; Matsushita S; Obaru K; Takatsuki K
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1291-9. PubMed ID: 9339846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.
    Gonzalez-Perez MP; Peters PJ; O'Connell O; Silva N; Harbison C; Cummings Macri S; Kaliyaperumal S; Luzuriaga K; Clapham PR
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.